NAFDAC alerts Nigerians to recall of children's ibuprofen in the US

The National Agency for Food and Drug Administration and Control NAFDAC has issued an alert to Nigerians regarding the recall of approximately 90,000 bottles of Children’s Ibuprofen Oral Suspension in the United States. The recall, initiated by Strides Pharma Inc., was due to the presence of foreign material, described as a “gel-like mass” and “black particles,” found within the medication. This product, Children’s Ibuprofen Oral Suspension, USP 100 mg/5 mL, is used to relieve pain in children. NAFDAC emphasized that foreign materials can compromise the quality, safety, and effectiveness of medicinal products. The affected products, manufactured by Strides Pharma Inc., India, for Taro Pharmaceuticals in the U.S., are packaged in 120 mL bottles with lot numbers 7261973A and 7261974A, and an expiry date of January 31, 2027. Although the recall is within the U.S., NAFDAC is taking proactive steps to prevent these products from entering the Nigerian market, directing zonal directors and state coordinators to intensify surveillance. The agency advises importers, distributors, retailers, healthcare professionals, and caregivers to avoid the importation, sale, distribution, or use of the recalled products. Healthcare facilities are urged to inspect inventories and quarantine any affected batches. Parents and caregivers with the affected products should discontinue use and seek medical attention if any unusual reactions are observed in children. NAFDAC encourages reporting of adverse